Bone Biologics Corp. BBLG 深 沪
等待开盘 12-19 09:30:00 美东时间
1.857
-0.143
-7.15%
华盛通- 最 高1.9126
- 今 开1.91
- 成交量 1.23万股
- 最 低 1.82
- 昨 收 2.00
- 总市值 333.39万
- 52周最高 7.74
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 1.30
- 委 比 92.92%
- 总股本 179.53万
- 历史最高 10255.68
- 量 比 0.67
- 振 幅 4.63%
- 历史最低 1.82
- 每 手 1
- 风险率 1.63%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Watching Bone Biologics; Zacks Small-Cap Research Gives Stock $22.25 Price Valuation
https://s27.q4cdn.com/906368049/files/News/2025/Zacks_SCR_Research_11172025_BBLG_Sorensen.pdf
11-18 01:05
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Bone Biologics (NASDAQ:BBLG) shares increased by 30.4% to $2.7 during ...
09-04 20:08
Bone Biologics CEO Issues Stockholder Letter Highlighting NB1 Clinical Progress, Product Improvements, Year-End Enrollment Goal, Expanded Shelf Life, Interim Trial Update, And 2026 Financial Outlook
One-Year OutlookThe firm expect to achieve a number of value-creating events in the coming year under our cost-efficient business model, including the following:Adding additional hospital sites in Australia and
09-04 19:08
Bone Biologics Q2 EPS $(1.33) Misses $(0.58) Estimate
Bone Biologics (NASDAQ:BBLG) reported quarterly losses of $(1.33) per share which missed the analyst consensus estimate of $(0.58) by 129.31 percent. This is a 66.92 percent increase over losses of $(4.02) per share from
08-15 05:50
SI-BONE To Report Second Quarter 2025 Financial Results on August 4, 2025
SI-BONE, a medical device company focused on sacropelvic disorders, will report its second quarter 2025 financial results on August 4, 2025, after market close. Management will host a conference call at 4:30 p.m. ET, available for investors via registration. SI-BONE, a global leader in minimally invasive SI joint fusion, has supported over 125,000 procedures since launching its iFuse system in 2009, with over 175 peer-reviewed publications suppor...
07-14 20:09
Why Is Bone Biologics Stock Surging On Friday?
Bone Biologics filed a USPTO patent for NELL-1 and announced a $5 million offering to support trials and expand its bone regeneration patent portfolio.
06-27 22:23
Bone Biologics shares are trading higher after the compnay announced it filed a USPTO patent for rhNELL-1.
Bone Biologics shares are trading higher after the compnay announced it filed a...
06-27 20:16
Market-Moving News for June 27th
NKE: 11% | Nike Q4 Earnings: Revenue Beat, EPS Beat, Headwinds Expected To Moderate Moving Forward, Company Playing 'Sport Offense' BBLG: 188% | Bone Biologics Files USPTO Patent For rhNELL-1 Protein In
06-27 19:22
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Plus Therapeutics (NASDAQ:PSTV) stock increased by 66.2% to $0.31 duri...
06-26 01:06
Bone Biologics files $35M mixed shelf offering
Bone Biologics (NASDAQ:BBLG) has filed to offer up to $35M in securities through a shelf registration. The offering may include common stock, preferred stock, warrants, rights, or units in various com...
06-25 05:19
